医学
疤痕
科克伦图书馆
荟萃分析
随机对照试验
可视模拟标度
患者满意度
外科
系统回顾
梅德林
麻醉
内科学
政治学
法学
作者
Wenhui Yang,Guangxue Li
摘要
Abstract Background Active prevention and treatment of scars are particularly important. Several studies have used botulinum toxin type A(BTXA) to prevent postoperative scarring. The aim of this systematic review and meta‐analysis was to systematically evaluate the efficacy and safety of BTXA in preventing and treating postoperative scars. Methods A computer‐based search was conducted for the five databases including PubMed, Cochrane Library, EMBASE, CNKI, and Wanfang up to May 22, 2019, to collect the relevant literatures on BTXA treatment of postoperative hypertrophic scars. A meta‐analysis was made with the software of Revman 5.3 based on the study endpoint of scar width, Vancouver Scar Scale (VSS), Visual Analogue Scale (VAS) scores, and patient satisfaction as well. Results A total of 18 randomized controlled trials (RCTs) studies were included with 915 patients in all. The result showed that, compared with the control group, the scar width, VAS scores, and VSS scores of the BTXA group were significantly improved and higher patient satisfaction was achieved. Conclusion BTXA has a certain curative effect on postoperative scar prevention and treatment without obvious side effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI